CEACAM5 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM5 monoclonal antibodies for research in cancer biology and cellular signaling. CEACAM5 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM5, also known as Carcinoembryonic Antigen (CEA), plays a critical role in cell adhesion and is often overexpressed in various types of cancers, making it a significant biomarker for tumor diagnosis and monitoring. Its involvement in tumor progression and metastasis highlights the importance of CEACAM5 in cancer research, providing insights into potential therapeutic targets. CEACAM5 expression patterns can be effectively analyzed across different tissue types and experimental conditions. Researchers can track CEACAM5 localization and expression levels in both normal and pathological states. Understanding CEACAM5's role in cellular processes helps advance cancer diagnostics and treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for CEACAM5 support researchers worldwide in advancing cancer research and therapeutic development.